1. Home
  2. TKNO vs JRI Comparison

TKNO vs JRI Comparison

Compare TKNO & JRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TKNO
  • JRI
  • Stock Information
  • Founded
  • TKNO 1996
  • JRI 2012
  • Country
  • TKNO United States
  • JRI United States
  • Employees
  • TKNO N/A
  • JRI N/A
  • Industry
  • TKNO Medicinal Chemicals and Botanical Products
  • JRI Finance Companies
  • Sector
  • TKNO Health Care
  • JRI Finance
  • Exchange
  • TKNO Nasdaq
  • JRI Nasdaq
  • Market Cap
  • TKNO 256.9M
  • JRI 367.7M
  • IPO Year
  • TKNO 2021
  • JRI N/A
  • Fundamental
  • Price
  • TKNO $4.35
  • JRI $13.57
  • Analyst Decision
  • TKNO
  • JRI
  • Analyst Count
  • TKNO 0
  • JRI 0
  • Target Price
  • TKNO N/A
  • JRI N/A
  • AVG Volume (30 Days)
  • TKNO 224.0K
  • JRI 68.0K
  • Earning Date
  • TKNO 08-07-2025
  • JRI 01-01-0001
  • Dividend Yield
  • TKNO N/A
  • JRI 9.38%
  • EPS Growth
  • TKNO N/A
  • JRI N/A
  • EPS
  • TKNO N/A
  • JRI N/A
  • Revenue
  • TKNO $38,923,000.00
  • JRI N/A
  • Revenue This Year
  • TKNO $9.52
  • JRI N/A
  • Revenue Next Year
  • TKNO $15.20
  • JRI N/A
  • P/E Ratio
  • TKNO N/A
  • JRI N/A
  • Revenue Growth
  • TKNO 11.40
  • JRI N/A
  • 52 Week Low
  • TKNO $4.00
  • JRI $9.70
  • 52 Week High
  • TKNO $10.37
  • JRI $12.12
  • Technical
  • Relative Strength Index (RSI)
  • TKNO 43.35
  • JRI 65.61
  • Support Level
  • TKNO $4.22
  • JRI $13.27
  • Resistance Level
  • TKNO $4.94
  • JRI $13.48
  • Average True Range (ATR)
  • TKNO 0.29
  • JRI 0.10
  • MACD
  • TKNO -0.00
  • JRI 0.01
  • Stochastic Oscillator
  • TKNO 16.75
  • JRI 96.87

About TKNO Alpha Teknova Inc.

Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its offer three product types: pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It derives key revenue from United States.

About JRI Nuveen Real Asset Income and Growth Fund of Beneficial Interest

Nuveen Real Asset Income and Growth Fund is the United States-based closed-end fund. Its objective is to provide a high level of current income and long-term capital appreciation. The fund invests a majority of its managed assets in equity and debt securities issued by real asset related companies located anywhere in the world. Its plan involves investments in five security types, infrastructure common stock, REIT preferred stock and debt securities. Real asset-related companies include those engaged in owning, operating, or developing infrastructure projects, facilities, and services, as well as REITs.

Share on Social Networks: